Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linzhao Cheng

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Stem Cell Reports|February 11, 2014
A panel of CpG methylation sites distinguishes human embryonic stem cells and induced pluripotent stem cellsKevin Huang, Yin Shen, Zhigang Xue, et al.
Cell Stem Cell|July 5, 2014
Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCsCory Smith, Athurva Gore, Wei Yan, et al.
Cell Research|January 19, 2011
Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signaturesBin-Kuan Chou, Prashant Mali, Xiaosong Huang, et al.
Stem Cells (Dayton, Ohio)|October 10, 2013
Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cellsZhaohui Ye, Cyndi F Liu, Lucie Lanikova, et al.
Blood|October 3, 2009
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disordersZhaohui Ye, Huichun Zhan, Prashant Mali, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 5, 2013
Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factorsXiaosong Huang, Siddharth Shah, Jing Wang, et al.
American Journal of Hematology|November 15, 2021
Erythropoietic properties of human induced pluripotent stem cells-derived red blood cells in immunodeficient miceJiusheng Deng, Moira Lancelot, Ryan Jajosky, et al.
Plos One|June 9, 2020
iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieuItzy E Morales Pantoja, Matthew D Smith, Labchan Rajbhandari, et al.
Plos One|April 26, 2017
A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC modelXuan Yuan, Zhe Li, Andrea C Baines, et al.
Stem Cells Translational Medicine|November 23, 2017
A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell DiseaseLiuhong Cai, Hao Bai, Vasiliki Mahairaki, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Stem Cell Reports|February 11, 2014
A panel of CpG methylation sites distinguishes human embryonic stem cells and induced pluripotent stem cellsKevin Huang, Yin Shen, Zhigang Xue, et al.
Cell Stem Cell|July 5, 2014
Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCsCory Smith, Athurva Gore, Wei Yan, et al.
Cell Research|January 19, 2011
Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signaturesBin-Kuan Chou, Prashant Mali, Xiaosong Huang, et al.
Stem Cells (Dayton, Ohio)|October 10, 2013
Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cellsZhaohui Ye, Cyndi F Liu, Lucie Lanikova, et al.
Blood|October 3, 2009
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disordersZhaohui Ye, Huichun Zhan, Prashant Mali, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 5, 2013
Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factorsXiaosong Huang, Siddharth Shah, Jing Wang, et al.
American Journal of Hematology|November 15, 2021
Erythropoietic properties of human induced pluripotent stem cells-derived red blood cells in immunodeficient miceJiusheng Deng, Moira Lancelot, Ryan Jajosky, et al.
Plos One|June 9, 2020
iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieuItzy E Morales Pantoja, Matthew D Smith, Labchan Rajbhandari, et al.
Plos One|April 26, 2017
A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC modelXuan Yuan, Zhe Li, Andrea C Baines, et al.
Stem Cells Translational Medicine|November 23, 2017
A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell DiseaseLiuhong Cai, Hao Bai, Vasiliki Mahairaki, et al.
Pageof 14